Exercise and pharmacological treatment: influence on locomotor activity in SHR rats
Keywords:aerobic, augmentation, pramipexole, restless legs syndrome
Restless legs syndrome (RLS) is characterized by abnormal sensations in the lower limbs and negatively impacts on sleep. Dopaminergic agonists (pramipexole, PPX) may be used in the treatment. However, chronic use may cause worsening of symptoms (augmentation). Physical exercise (PE) also may be effective in reducing RLS symptoms and improving the sleep pattern. The main purpose of this study was to evaluate the effect of PPX and acute PE on locomotor activity (RLS symptoms) of spontaneously hypertensive rats (SHR). Animals were distributed into 4 groups: Saline, PPX1 (0.1 mg/kg) at 75 days of age, PPX2 (0.05 mg/kg) at 91 days of age and PPX3 (0.05 mg/kg) at 125 days of age.The animals received a daily injection of PPX or saline (07:00 h) for 48 days. The PE (treadmill) consisted of a single session (30 min) at 20–22 m/min. The evaluation of locomotor activity (open field) was performed at baseline and weekly, after administration of the drug. Both PPX and PE caused changes in locomotor activity (RLS symptoms), on specific days. The groups that received PPX had weight changes when compared with the saline groups, but without manifestation of the augmentation.
How to Cite
Copyright (c) 2019 Nádia Esteves dos Santos, Camila Aparecida Sansão Coelho, Milca Abda de Morais, Beatriz da Silva Franco, Andrea Maculano Esteves
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors must declare that the work submitted is their own and that copyright has not been breached in seeking its publication. If the manuscript includes work previously published elsewhere, it is the author(s) responsibility to obtain permission to use it and to indicate that such permission has been granted.
Authors retain the copyright of their paper and grant the Brazilian Journal of Motor Behavior (BJMB) the right to first publish the work under a Creative Commons Attribution-NonCommercial-NoDerivatives license (CC BY-NC-ND). This license allows users to share the paper given the appropriate credit to the author and source and does not allow commercial uses and derivative materials to be produced.